Ra
Rapafusyn
San Antonio TXFounded 201710 employees
Private CapbiotechPrivateOncology
Platform: Rapalink mTOR
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
3
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Tixatuximab | RAP-7340 | Phase 3 | 2 | PRMT5 | MDDOCD | ||
| Nirarasimod | RAP-2654 | Phase 2/3 | 1 | PARP | NMOSDLN |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)